Top news of the week: 22.04.2021.
Startups
Antibody Startup Adagio Raises $336 Million To Develop A Variant-Proof Treatment For Covid-19
The new company says it has a monoclonal antibody that is effective against all currently known variants of the coronavirus.
Biotech Funding Tops The Charts Again
Another quarter, another set of all-time highs for biotech funding – and this surfeit of capital continues raises possible concerns about its disciplined deployment. Back in January, when ...
The Billionaire Scientist Behind The Pfizer Vaccine Has Not Sold A Single Share Of His Booming Stock
Uğur Şahin has not sold any of his BioNTech shares, even as their value soared by 900% in the pandemic, in stark contrast to the executives behind other prominent vaccine efforts.
With money pouring into biotech, Versant raises another $950M
Versant's announcement comes as biotechs continue to rake in record levels of cash, supporting a wave of new drug company startups.
New England Aquarium partners with SeaAhead to launch ocean-centric startups
The ocean is a massive ecosystem, so why shouldn’t it have a startup ecosystem all its own? That’s the thinking behind the new BlueSwell Incubator Program hosted by the New England Aquarium ...
Rapha Capital Management launches $100M life science VC fund with an eye on early science
Life science venture capital firm Rapha Capital Management has launched its first managed venture capital fund with a target raise of $100M and “solely focused” on investment in early-stage ...
Covid has turned universities into healthcare startup factories
The pandemic has sparked a new generation of academic-led healthtech startups, and universities are raking in millions
Regenerative medicine biotech Surrozen aims for the Nasdaq in $212M SPAC deal
After banking two $50 million venture rounds about a year apart, Surrozen is ready to hit Wall Street. The company plans to go public via SPAC in a deal worth up to $212 million. ...